Studies on Hypolipemic Effect of Cyclocarya paliurus Batal Iljinskaja Polysaccharide

Similar documents
Effect of Ca 2 + /CaM Messenger on Drought Resistance of Phyllostachys edulis

2 1 Liu Chunji 2 Kemal Kazan 2. Studies on Conditions for Sporulation of Pathogen Fusarium pseudograminearum

Detection of Rice Black-streaked Dwarf Virus and Southern Rice BlackstreakedDwarf Virus and Their Regional Distribution in Jiangxi Province

Journal of Chemical and Pharmaceutical Research, 2017, 9(3): Research Article

NDO NSP. YI Zhong-hua ZHU Nian-hua LI Guan-hong SONG Xiao-zhen PAN Ke QU Ming-ren

A New Environment-friendly Avermectin Microemulsion Formulation

Therapeutic effect of flavonoid rich extract of apricots on high-fat diet induced hyperlipidemia in rabbits

STATIN UTILIZATION MANAGEMENT CRITERIA

THE EFFECT OF VITAMIN-C THERAPY ON HYPERGLYCEMIA, HYPERLIPIDEMIA AND NON HIGH DENSITY LIPOPROTEIN LEVEL IN TYPE 2 DIABETES

>27 years of old, were enrolled. The success rates for apo B and LDL-C goal attainments were evaluated and compared by categorization and by sex.

Figure S1. Comparison of fasting plasma lipoprotein levels between males (n=108) and females (n=130). Box plots represent the quartiles distribution

290 Biomed Environ Sci, 2016; 29(4):

Hae Sun Suh, B.Pharm., Ph.D. Jason N. Doctor, Ph.D.

Update on Dyslipidemia and Recent Data on Treating the Statin Intolerant Patient

Effects of Luffa acutangula L. (Cucurbitaceae) Fruit Extract on the Blood. Lipid Profile of Albino Rats

Identification of Endophytic Fungi Strain R2 from Ginkgo biloba and Its Antimicrobial Activity

Evaluation of the Efficacy of Flaxilip Capsule for Hypercholesterolemic Patients

International Journal of Research and Development in Pharmacy and Life Sciences. Research Article

Hyperlipidemia. Prepared by : Muhannad Mohammed Supervisor professor : Dr. Ahmed Yahya Dallalbashi

Researches on Fermentation Engineering of Polysaccharide of

PIEDMONT ACCESS TO HEALTH SERVICES, INC. Guidelines for Screening and Management of Dyslipidemia

Int J Clin Exp Med 2015;8(4): /ISSN: /IJCEM Jianjun Yin 1,3, Daoqun Jin 2,3, Hong Wang 1,3

PATIENT INFORMATION. Medicine To Treat: C ardiac Diseases. Lipid-Lowering Medicines. Statins Fibrates Fat Binding Agents Nicotinic Acid Group

Males- Western Diet WT KO Age (wks) Females- Western Diet WT KO Age (wks)

Composition and Structure of Oil and Fats and its Relationship to Health and Nutrition

Management of Post-transplant hyperlipidemia

The changes of serum BDNF, blood lipid and PCI in the elderly patients with coronary heart disease complicated with diabetes mellitus

Friedewald formula. ATP Adult Treatment Panel III L D L Friedewald formula L D L = T- C H O - H D L - T G / 5. Friedewald formula. Friedewald formula

Natural Products have proven effective for the treatment of Cardiovascular diseases.

Zuhier Awan, MD, PhD, FRCPC

EFFECT OF LYCOPENE IN TOMATO SOUP AND TOMATO JUICE ON THE LIPID PROFILE OF HYPERLIPIDEMIC SUBJECTS

Serum levels of galectin-1, galectin-3, and galectin-9 are associated with large artery atherosclerotic

Changes and clinical significance of serum vaspin levels in patients with type 2 diabetes

BCH 447. Triglyceride Determination in Serum

Lipids Testing

Common Repatha Documentation Requirements for Patients With Primary Hyperlipidemia and Established CVD 1,2

MOLINA HEALTHCARE OF CALIFORNIA

Metabolism, Atherogenic Properties and Agents to reduce Triglyceride-Rich Lipoproteins Manfredi Rizzo, MD, PhD

Extracts of Moringa oleifera a sure bet for Hyperlipidemia management

Association between matrix metalloproteinase-9 rs polymorphism and development of coronary artery disease in a Chinese population

Summary and Conclusions

Cholesterol, Heart Attack and Stroke. Dr Tai E Shyong Consultant Department of Endocrinology Singapore General Hospital

AstaREAL, natural Astaxanthin Nature s way to fight the metabolic syndrome

Andrew Cohen, MD and Neil S. Skolnik, MD INTRODUCTION

Diabetes. J Med Food Winter;4(4): Role of Spirulina in the Control of Glycemia and Lipidemia in Type 2 Diabetes Mellitus.

Fig. S1. REGN1500 reduces plasma levels of cholesterol, TG and NEFA in WT and Ldlr -/- mice. (A) WT

Health benefits of mango supplementation as it relates to weight loss, body composition, and inflammation: a pilot study

Studies on the Genetic Diversity of Farmed and Wild Populations of Coilia nasus by Analysing Mitochondrial DNA Cyt b genes

Hydrophobic Surfactant Treatment Prevents Atherosclerosis in the Rabbit

Pathophysiology of Lipid Disorders

Supplementary Figure S I: Effects of D4F on body weight and serum lipids in apoe -/- mice.

Macrovascular Management. What s next beyond standard treatment?

Treating the Cause to Prevent and Reverse Heart Disease. Caldwell B. Esselstyn Jr., M.D.

UCLA Nutrition Bytes. Title. Permalink. Journal ISSN. Author. Publication Date. Spice Up Your Lipids: The Effects of Curcumin on Lipids in Humans

NEW GUIDELINES FOR CHOLESTEROL

Downloaded from journal.bums.ac.ir at 23:16 IRST on Saturday February 16th 2019

Lipids, Lipoproteins and Cardiovascular Risk: Getting the Most out of New and Old Biomarkers. New and Old Biomarkers. Disclosures

Plasma fibrinogen level, BMI and lipid profile in type 2 diabetes mellitus with hypertension

Cardiovascular risk potential of dietary saturated fats: an update and some implications

Joshua Shepherd PA-C, MMS, MT (ASCP)

Chronic Kidney Disease as cardiovascular risk predictor Evidence based clinical management. Fabio Mazza

The investigation of serum lipids and prevalence of dyslipidemia in urban adult population of Warangal district, Andhra Pradesh, India

Antihyperlipidemic Drugs

Ezetimib Stada 10 mg tablets

Cardiovascular Division, Affiliated Hospital of the North China University of Technology, Tangshan, Hebei, China

Non-fasting Lipid Profile Getting to the Heart of the Matter! Medimail Dec 2017

Clinical study of Huxinkang tablet in treating unstable angina pectoris

Creating Healthier Lives. Cholesterol Reduction Complex Lower Your Cholesterol Naturally

Lipids: Translating Studies into Practice. WD04: Cortney Joneikis, MD, MS Bob Gleeson, MD Jeff Whittle, MD, MPH

Antihyperlipidemic Drugs

Dyslipidemia. Team Members: Laila Mathkour, Khalid Aleedan, Bayan Al-Mugheerha, Fatima AlTassan

Statin, Pleiotropic effect, Oxidized low-density lipoprotein

International Journal of Allied Medical Sciences and Clinical Research (IJAMSCR)

YOUR INFORMATION. Ischemic Heart Disease

LDL How Low can (should) you Go and be Safe

Replacement Of Partially Hydrogenated Soybean Oil By Palm Oil In Margarine Without Unfavorable Effects On Serum Lipoproteins

Lipids Board Review. Ira Goldberg, MD New York University School of Medicine. Which of the following is the best initial therapy choice?

4/14/2018 DYSLIPIDEMIA CASES. Mary Malloy, MD. I have nothing to disclose

Inspired Functional Ingredients to Innovate and Differentiate Your Brand. Products by Ecovatec Solutions Inc.

Association of serum adipose triglyceride lipase levels with obesity and diabetes

Maintain Cholesterol

2.5% of all deaths globally each year. 7th leading cause of death by % of people with diabetes live in low and middle income countries

INTRODUCTION. Key Words:

Review of guidelines for management of dyslipidemia in diabetic patients

Ο ρόλος των τριγλυκεριδίων στην παθογένεια των μικροαγγειοπαθητικών επιπλοκών του σακχαρώδη διαβήτη

Letter to the Editor. Association of TCF7L2 and GCG Gene Variants with Insulin Secretion, Insulin Resistance, and Obesity in New-onset Diabetes *

殧 KCNJ11 11 KCNJ11 8 KCNJ11 P < KCNJ11 HDL-C. TT CT t = P =

ATP III (Adult Treatment Panel III) CLASSIFICATION C IN ADULTS

High density lipoprotein metabolism

See Important Reminder at the end of this policy for important regulatory and legal information.

Dyslipidemia. (Med-341)

New Developments in Health and Nutritional Function Promoted by Chicken Eggs

24 (TUDCA) TUDCA TUDCA. [DOI] /j.issn

B. Patient has not reached the percentage reduction goal with statin therapy

Lipid Therapy: Statins and Beyond. Ivan Anderson, MD RIHVH Cardiology

What is Diabetes Mellitus?

HIGH LDL CHOLESTEROL IS NOT AN INDEPENDENT RISK FACTOR FOR HEART ATTACKS AND STROKES

Seasonal Changes in Leaf Magnesium and Boron Contents and Their Relationships to Leaf Yellowing of Navel Orange Citrus sinensis Osbeck

CETP inhibition: pros and cons. Philip Barter The Heart Research Institute Sydney, Australia

DYSLIPIDEMIA PHARMACOLOGY. University of Hawai i Hilo Pre- Nursing Program NURS 203 General Pharmacology Danita Narciso Pharm D

Transcription:

2011 33 1 0157-0161 http / /xuebao. jxau. edu. cn Acta Agriculturae Universitatis Jiangxiensis E - mail ndxb7775@ sina. com * / 330045 2 300 mg /kg 200 mg /kg 100 mg /kg 3 mg /kg + 3 mg /kg + 200 mg / kg 4 2 TC TG HDL - C LDL - C TC LDL P < 0. 01 300 mg /kg /d Q946. 3 A 1000-2286 2011 01-0157 - 05 Studies on Hypolipemic Effect of Cyclocarya paliurus Batal Iljinskaja Polysaccharide HUANG Ming-quan SHANGGUAN Xin-chen XU Ming-sheng WANG Wen-jun * SHEN Yong-gen JIANG Yan CHEN Qin CHEN Ting-ting College of Food Science and Engineering /Research Lab for Plant Resource Development and Utilization Jiangxi Agricultural University Nanchang 330045 China Abstract The hypolipemic effect of Cyclocarya paliurus Batal Iljinskaja polysaccharide was study by in vivo and in vtro experments. The hypolipemic effect of Cyclocarya paliurus Batal Iljinskaja polysaccharide was detected in vitro by measuring the activity of pancreatic lipase. A test model of mice was made according to lipid level of the animals. The animals were divided into 7 groups the group with high dosages H polysaccharide 300 mg /kg the group with medium dosages M polysaccharide 200 mg /kg the group with low dosages L polysaccharide 100 mg /kg the group of simvastatin ST 3 mg /kg the group of simvastatin + medium dosages ST + M 3 mg /kg + 200 mg /kg the model group with hyperlipidemia and the normal group. All the mice were fed for. Then the influences of Cyclocarya paliurus Batal Iljinskaja polysaccharide on triglycerides TG total cholesterol TC low density lipoprotein cholesterol LDL and high density lipoprotein cholesterol HDL of serum in mice were determined every second week. Cyclocarya paliurus Batal Iljinskaja polysaccharide could inhibit the activity of pancreatic lipase in vitro. In the animal test polysaccharide could remarkably reduce the level of serum TC and 2010-09 - 09 2010-10 - 27 2002EA730001 2009BGA01900 2009GZN0014 YC09A067 1985 E - mail quanforice0620@ 163. com * E - mail wwjun9999@ sina. com

158 33 LDL P < 0. 01 the effect of high dosages was the best almost as effective as that of the group of sinvastatin. All this suggests that Cyclocarya paliurus Batal Iljinskaja polysaccharide has good hypolipemic effect. Key words Cyclocarya paliurus Batal Iljinskaja polysaccharide hyperlipemia hypolipemic effect 1 2 3-4 5-8 9 10-19 20 1 1. 1 1. 1. 1 10 5 h 2 2 sevage 70% 21-22 10% 89% 1% - 80 4 021-9601 1. 1. 2 TC TG HDL - C LDL - C Sigma 1. 2 1. 2. 1 23 100 ml 12 4 3 5 ml 0. 025 mol /L 4 ml 40 5 min 1 3 1 ml 30 min 95% 15 ml 3 0. 05 mol /L 3 2 3 1 ml 1 1 3 1. 2. 2 2 6 + 1. 2. 3 300 mg /kg 200 mg /kg 100 mg /kg 3 mg /kg 4 12 h TC TG HDL - C LDL - C 1. 2. 4 ± DPS V3. 01 2 2. 1 1 NaOH 3. 35 ml 2. 33 ml

1 159 NaOH Tab. 1 1 The activity of pancreatic lipase Lipase + Without lipase Polysaccharide + lipase Polysaccharide without lipase NaOH /ml 4. 30 3. 95 3. 80 0. 70 0. 65 0. 65 3. 50 3. 00 3. 30 0. 90 1. 00 0. 90 NaOH 4. 02 0. 67 3. 27 0. 93 Average NaOH 3. 35 2. 33 2. 2 2. 2. 1 TC 2 4 2 2 2 + P < 0. 01 4 4 + Tab. 2 2 TC The effect of polysaccharide on TC 2 Treatment for /% 4 Treatment for /% Normal 9 3. 93 ± 0. 88 3. 72 ± 1. 27 ** 5. 34 3. 88 ± 0. 71 ** 1. 27 H 15 10. 61 ± 3. 88 ** 4. 37 ± 1. 44 ** 58. 81 4. 21 ± 0. 35 ** 60. 32 M 14 8. 98 ± 1. 71 4. 34 ± 0. 58 ** 51. 67 4. 32 ± 0. 53 ** 51. 89 L 13 8. 23 ± 1. 63 4. 87 ± 1. 55 ** 40. 83 4. 15 ± 0. 58 ** 49. 57 ST + M 12 7. 82 ± 1. 61 3. 75 ± 1. 21 ** 52. 05 3. 05 ± 0. 44 ** 61. 00 ST 14 8. 91 ± 2. 41 3. 97 ± 0. 91 ** 55. 44 3. 68 ± 0. 78 ** 58. 70 Model 12 9. 46 ± 1. 79 * 6. 29 ± 1. 37 33. 51 6. 05 ± 0. 82 36. 05 * P < 0. 05 ** P < 0. 01 2. 2. 2 TG 2 4 3 3 TG Tab. 3 3 TG The effect of polysaccharide on TG 2 Treatment for /% 4 Treatment for /% Normal 9 1. 97 ± 0. 50 1. 83 ± 0. 93 7. 10 1. 88 ± 0. 21 4. 57 H 15 1. 97 ± 0. 49 1. 58 ± 0. 65 19. 80 1. 26 ± 0. 34 36. 04 M 14 1. 57 ± 0. 39 1. 39 ± 0. 70 11. 46 1. 15 ± 0. 59 26. 75 L 13 2. 38 ± 0. 37 1. 59 ± 0. 34 33. 19 1. 57 ± 0. 37 34. 03 ST + M 12 2. 07 ± 0. 59 1. 63 ± 0. 91 21. 26 1. 53 ± 0. 61 26. 09 ST 14 1. 46 ± 0. 59 1. 24 ± 0. 91 15. 07 1. 03 ± 0. 17 29. 45 Model 12 1. 56 ± 0. 58 1. 40 ± 0. 33 10. 26 1. 49 ± 0. 25 4. 49

160 33 2. 2. 3 HDL 2 4 4 4 2 4 HDL HDL HDL Tab. 4 4 HDL The effect of polysaccharide on HDL 2 Treatment for /% 4 Treatment for /% Normal 9 1. 49 ± 0. 68 1. 30 ± 0. 41 1. 45 ± 0. 37 H 15 1. 30 ± 0. 49 1. 44 ± 0. 42 10. 77 2. 03 ± 0. 42 ** 56. 15 M 14 1. 64 ± 0. 75 1. 42 ± 0. 56 2. 11 ± 0. 23 ** 28. 66 L 13 1. 44 ± 0. 56 1. 22 ± 0. 58 1. 89 ± 0. 46 ** 31. 25 ST + M 12 1. 13 ± 0. 39 1. 11 ± 0. 32 1. 99 ± 0. 58 ** 76. 11 ST 14 0. 93 ± 0. 67 0. 96 ± 0. 45 1. 45 ± 0. 46 * 55. 91 Model 12 1. 57 ± 0. 75 0. 81 ± 0. 31 3. 22 0. 83 ± 0. 11 * P < 0. 05 ** P < 0. 01 2. 2. 4 LDL 2 4 5 5 2 LDL P < 0. 01 4 2 + 2 LDL 5 LDL Tab. 5 The effect of polysaccharide on LDL 2 Treatment for /% 4 Treatment for /% Normal 9 0. 58 ± 0. 24 0. 71 ± 0. 24 ** 0. 68 ± 0. 11 ** H 15 4. 84 ± 0. 50 0. 63 ± 0. 22 ** 86. 98 0. 68 ± 0. 23 ** 85. 95 M 14 2. 92 ± 0. 84 0. 60 ± 0. 31 ** 79. 45 0. 65 ± 0. 12 ** 77. 74 L 13 3. 23 ± 1. 12 0. 79 ± 0. 56 ** 75. 54 0. 73 ± 0. 09 ** 77. 40 ST + M 12 3. 24 ± 1. 84 1. 07 ± 0. 76 ** 66. 98 0. 64 ± 0. 15 ** 80. 25 ST 14 3. 05 ± 1. 76 0. 72 ± 0. 48 ** 76. 39 0. 71 ± 0. 22 ** 76. 72 Model 12 4. 46 ± 1. 64 2. 72 ± 0. 50 39. 01 2. 93 ± 0. 51 34. 30 * P < 0. 05 ** P < 0. 01 3 NaOH 24 TC LDL

1 161 TG HDL 2 TC TG LDL HDL 25-3 27 TC LDL TG HDL + TC LDL P < 0. 01 TG HDL 300 mg / kg d 1. J. 2003 32 2 120-122. 2. J. 2003 25 2 212-214. 3. J. 2003 42 1 73-77. 4. J. 2006 28 6 809-812. 5. J. 2001 13 3 52-54. 6. J. 2003 31 6 117-120. 7. J. 2001 20 5 1-4. 8 Kurihara H Harukazu L Shibata H et al. Hypoglycemic action of Cyclocarya paliurus in normal and diabetic mice J. Biosci Biotechnol Biochem 2003 67 4 877-880. 9. J. 2004 16 5 59-60. 10. J. 2005 27 1 79-80. 11. J. 2005 30 11 1012-1013. 12. J. 2006 31 9 35-36. 13. J. 2000 31 10 764-765. 14 Kurihara H Sumio A Shibata H et al. Hypolipemic effect of Cyclocarya paliurus Batal Iljinskaja in lipid - loaded mice J. Biol Pharm Bull. 2003 26 3 383-385. 15 Yuan L J Tu D W Wu J P et al. Hypoglycemic and hypocholesterolemic effects of coptis chinensis franch inflorescence J. Plant Foods Human Nutr. 2006 61 139-144. 16 Lee H S Yoo C B Ku S K et al. Hypolipemic effect of water extracts of Picrorrhiza kurroa in high fat diet treated mouse J. Fitoterapia 2006 77 7-8 579-584. 17 Martinello F Soares S M Franco J J et al. Hypolipemic and antioxidant activities from Tamarindus indica L. pulp fruit extract in hypercholesterlolemic hamsters J. Food Chem Toxicol 2006 44 6 810-818. 18 Zaborska B Klos J Sikora - Frac M et al. Micronized fenofibrate decreased triglyceride levels total cholesterol and LDL fractions in serum J. Pol Arch Med Wewn 2000 104 1 371-375. 19 Juzwiak S Wojcicki J Mokrzycki K et al. Effect of quercetin on experimental hyperlipidemia and atherosclerosis in rabbits J. Pharmacol Rep 2005 57 5 604-609. 20 Sovova M Sova P. Pharmaceutical importance of Allium sativum L. hypolipemic effects in vitro and in vivo J. Ceska Slov Farm 2004 53 3 117-123. 21. J. 2002 178 4 466. 22. J. 1994 29 387-389. 23. M. 1994 311-312. 24. M. 2. 1994 1757-1767. 25. J. 2002 9 5 355-356. 26 Pulkowski G Fabisiak J. The effect of hypolipemic therapy with diet and simvastatin on the course of angina pectoris and the results of exercise stress test in patients with coronary artery disease J. Pol Arch Med Wewn 2005 114 2 746-754. 27 Buemi M Nostro L Crascì E et al. Statins in nephrotic syndrome a new weapon against tissue injury J. Med Res Rev 2005 25 6 587-609.